Loading patent…
AssigneeGuangzhou Hanfang Pharmaceutical Co., Ltd.
InventorsJuyan Liu, Wendong Xu, Hongfei Cai, Jing Li, Cheng Yuan, Yaming Han, Lin Cao, Shunzhi Tang, Yukang Mao, Guocai Wang, Qin Zhang
Estimating the term…
Ganoderma lucidum spore oil and use thereof in the preparation of anti-cancer-related fatigue medicaments are provided. The content of triglycerides in the Ganoderma lucidum spore oil is greater than 90%. Ganoderma lucidum triterpenoids are not detected. The Ganoderma lucidum spore oil is extracted by means of supercritical CO2, eluted with a silica gel column and a mixed solution of petroleum ether-ethyl acetate, concentrated under reduced pressure and vacuum-dried. The Ganoderma lucidum spore oil is highly effective in mitigating cancer-related fatigue, has good safety, and can be used in the preparation of medicaments for treating cancer-related fatigue.
A method for reducing the incidence of or treating cancer-related fatigue, comprising administering to a subject in need thereof a therapeutically effective amount of Ganoderma lucidum spore oil, wherein no Ganoderma lucidum triterpenoids are detected in the Ganoderma lucidum spore oil.
Dependencies are inferred from the claim text.